RISK AND OUTCOMES FOLLOWING APPLICATION OF MULTI-PLANAR RING FIXATION SYSTEMS - A TWELVE YEAR REVIEW FROM A US CLAIMS DATABASE ANALYSIS
Author(s)
Reid S1, Vanderkarr M2, Ray B3, Chitnis AS4, Holy CE5
1Penn State Health, Hershey, PA, USA, 2DePuy Synthes, Inc., Bay Village, OH, USA, 3Mu Sigma, Bangalore , India, 4Johnson & Johnson, New Brunswick, NJ, USA, 5Johnson & Johnson, New Brunswick, MA, USA
OBJECTIVES Clinical outcomes from multi-planar ring fixation (MPRF) systems have been reported in relatively small case series, due to infrequent use. To further increase understanding of MPRF outcomes in larger populations, our study presents outcomes following MPRF application from one of the biggest claims databases in the United States. METHODS Patients with MPRF application were identified in the IBM Marketscan® Commercial Claims database between 2007-2018 and categorized by major diagnostic category including: acquired or congenital deformity (CD), fresh fractures or sequela from prior fractures (deep infection, non-union, other), arthropathy, other. Variables included patient demographics and comorbidities. Healthcare utilization and clinical outcomes (risk of deep and superficial infection, reoperation, amputation, and post-MPRF removal: risk of new osteotomy, fracture and new frame implantation) were analyzed up to 24 months post-application. Logistic regression models were built to evaluate risk factors for complications and generalized linear models were used to estimate payer costs. RESULTS 12,532 patients were included. The CD cohort included only pediatric cases whereas all other cohorts included pediatric and adult subjects. For all comorbidities and outcomes, the CD cohort was significantly different than other cohorts: At time of MPRF application, major comorbidities for CD were pulmonary disease (11.3%), hearing impairment (5.9%) and other neurological disorders (4.8%). For all others, major comorbidities included uncomplicated hypertension (23.3%), uncomplicated diabetes (14.0%) and depression (9.5%). Average treatment duration was 83.3 days (SD: 72.9), with significant variability within and across diagnostic categories. Overall superficial infection was the most common complication at 23.2%, followed by deep infection (9.8%). Adjusted risk for complications were significantly lower in the CD cohort compared to all other cohorts. CONCLUSIONS Pediatric cases presenting for deformity correction had unique comorbidities and clinical challenges compared to all other patients. Focused research by patient type is critical to further improve patient experience and outcomes.
Conference/Value in Health Info
2020-05, ISPOR 2020, Orlando, FL, USA
Value in Health, Volume 23, Issue 5, S1 (May 2020)
Code
PMD32
Topic
Epidemiology & Public Health, Medical Technologies
Topic Subcategory
Medical Devices
Disease
Medical Devices, Musculoskeletal Disorders, Surgery